BIOPSENSE
Live / Applied — Non-final action mailed (as of 20 Nov 2025)
What this means for you
Not registered yet, but its 11 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79424304
- Mark type
- Stylized text
- Filed
- 11 Apr 2025
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for scientific purposes; diagnostic reagents for scientific or research use; diagnostic reagents and preparations, except for medical or veterinary use; reagents for use with analyzers [other than for medical or veterinary purposes]; reagents for research purposes.
- Class 005 — Pharmaceuticals: Diagnostic reagents for medical use; diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; reagents for use with analyzers [for medical purposes]; reagents for use in diagnostic tests [for medical purposes].
- Class 009 — Scientific and electric apparatus: Diagnostic apparatus, not for medical purposes; separating apparatus for laboratory use; laboratory instruments [other than for medical use]; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids.
- Class 010 — Medical apparatus: Automated analyzers for foreign matter contained in body fluids [for medical use]; automated analyzers for body fluids [for medical use]; apparatus for DNA and RNA exams for medical purposes; apparatus for carrying-out diagnostic tests for medical purposes; medical diagnostic apparatus for medical purposes; analysers for medical use.
- Class 042 — Scientific and technological services: Biological laboratory services; design of diagnostic apparatus; medical research laboratory services.
- Class 044 — Medical, beauty and agricultural services: Laboratory analysis services relating to the treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services; RNA or DNA analysis for cancer diagnosis and prognosis.
Owner
- BiopSense Oy, FI
Prosecution history
- 05 Dec 2025 — REFUSAL PROCESSED BY IB
- 20 Nov 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 20 Nov 2025 — REFUSAL PROCESSED BY MPU
- 02 Oct 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 01 Oct 2025 — NON-FINAL ACTION WRITTEN
- 08 Sept 2025 — ASSIGNED TO EXAMINER
- 26 May 2025 — APPLICATION FILING RECEIPT MAILED
- 26 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 May 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB